Qiang Wei

Mr. Qiang Wei


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2022 in BMC Cancer
Verified
Journal Article
Open access
PDF file
HFHao Feng
Hao Feng
BCBoxiong Cao
Boxiong Cao
XPXuan Peng
Xuan Peng
QWQiang Wei
Qiang Wei
The tumor microenvironment is a dynamic cellular milieu that interacts with cancer cells and promotes tumor progression and metastasis. However, the specific mechanisms by which the tumor microenvironment impacts cancer cells’ behaviors remain poorly understood. In this study, enriched cancer-associated fibroblasts (CAFs) were observed in tumor tissues isolated from epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) resistant non-small cell lung cancer (NSCLC) patients. CAFs isolated from tumor tissues were capable of producing tryptophan metabolite kynurenine (Kyn), which significantly increased the proliferation and EGFR TKIs resistance of NSCLC cells. In this study, it was further observed that the activation of tryptophan 2,3-dioxygenase (TDO) in CAFs, resulted in the enhanced capability of tryptophan metabolism in them compared to normal fibroblasts. As a result, Kyn produced by CAFs facilitated the up-regulation of Aryl Hydrocarbon Receptor (AhR) signals in NSCLC, thereby resulting in the downstream ATK and ERK signaling pathways activation. Finally, inhibition of AhR signals efficiently prevented tumor growth and development of EGFR TKIs resistance, eventually improved the outcome of EGFR TKIs, and described a promising therapeutic strategy for NSCLC.

1 April 2025 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
ZHZemin He
Zemin He
KLKeting Liu
Keting Liu
LWLing Wu
Ling Wu
QWQiang Wei
Qiang Wei
QSQingwei Shen
Qingwei Shen
Objective: To analyze the screening results for pulmonary nodules before and after the COVID-19 epidemic to understand the influence of the COVID-19 epidemic on the detection rate of pulmonary nodules and the detection rate of high-risk pulmonary nodules.Methods: A total of 18,906 chest CT scans were performed between March and November 2022 and between March and November 2023. Subjects from March to December 2022 were divided into the pre-epidemic group, and subjects from March to December 2023 were divided into the post-epidemic group. The detection rates of lung nodules, high risk nodules, different age groups, and gender groups were analyzed.Results: A total of 11513 lung nodules were detected during screening. A total of 841 high risk nodules were detected, and the detection rate of solid nodules was significantly higher in the postepidemic group than in the pre-epidemic group. The detection rate of fibrotic changes was significantly higher in the postepidemic group than in the pre-epidemic group. The detection rate of pulmonary nodules is significantly higher in those aged > 51 years compared to those aged 50 years and below.Conclusion: In the post-COVID-19 period, there has been a significant increase in the detection of solid pulmonary nodules. This increased detection rate is predominantly observed in medical patients over 51 years of age. However, the COVID-19 epidemic has not resulted in an increased detection rate of high risk nodules.

1 November 2023
Verified
Journal Article
Closed access
GHGaigai Huang
Gaigai Huang
HFHao Feng
Hao Feng
YZYu Zhou
Yu Zhou
BCBoxiong Cao
Boxiong Cao
ZZZiliang Zan
Ziliang Zan
QWQiang Wei
Qiang Wei

17 January 2023 in European Journal of Inflammation
Verified
Journal Article
Open access
HFHao Feng
Hao Feng
GHGaigai Huang
Gaigai Huang
BCBoxiong Cao
Boxiong Cao
ZZZiliang Zan
Ziliang Zan
QWQiang Wei
Qiang Wei
Objectives: The development and progression of malignancies are closely linked to hypercoagulability. As an early type of lung adenocarcinoma, ground glass nodules (GGNs) have been detected increasingly. Blood Maximum amplitude (MA) and mean platelet volume (MPV) are related to various conditions of hypercoagulability. Therefore, the role of MA and MPV in diagnosing lung adenocarcinoma cancer featured with GGNs was investigated in this case-control study. Methods: The analyzed data of this study is derived from GGNs patients and healthy individuals in West China (Airport) Hospital Sichuan University. The differences between GGNs patients and healthy individuals were determined by one-way ANOVA, logistic regression or chi-squared test. The accuracy of diagnostic was performed by receiver operating characteristic curve (ROC). The relative mRNA expressions were studied by RT-qPCR. Results: 470 patients diagnosed with GGNs which benign lesions (BN group) are inflammatory and malignant lesions (LC group) are adenocarcinoma in stage IA, and 235 healthy subjects (HC group) were enrolled in this study. Levels of MA and MPV were increased in LC group compared with BN and HC group ( p < 0.001, p < 0.001). When we combined MA and MPV, MA and MPV presented a sensitivity (SEN) of 0.809 and a specificity (SPE) of 0.774. And the area under the curve (AUC) increased to 0.871 (0.837–0.900) when confidence interval was 95%. Conclusion: This study demonstrates that there have been systemic changes in coagulation disorders in the pathogenesis of GGNs. The diagnostic ability to different lung adenocarcinoma cancer featured with GGNs from benign or healthy controls can be improved by the combination of MA and MPV. Maximum amplitude and MPV may be used as biomarkers to detect lung adenocarcinoma cancer featured with GGNs.